Literature DB >> 9932229

Mutation of C-terminal tyrosine residues Y497/Y504 of the Src-family member Bsk/Iyk decreases NIH3T3 cell proliferation.

C Oberg-Welsh1, C Annerén, M Welsh.   

Abstract

To elucidate the properties of the Src-family member Bsk/Iyk, NIH3T3 cells were transfected with wild-type Bsk/Iyk or Bsk/Iyk carrying Y497F, Y504F or Y497/504F mutations. These positions are putatively homologous to tyr-527 in Src. The Bsk/IykY497/504F cells displayed a decreased cell growth rate, parallelled by an augmentation of the fraction of cells in G1-phase. The Bsk/IykY497/504F double-mutation decreased the [3H]thymidine incorporation. No effects on NIH3T3 cell growth could be seen in cells expressing wild-type Bsk/Iyk or the other Bsk/Iyk mutants. In vitro kinase reactions performed on immunoprecipitates from NIH3T3 cells expressing wild-type or mutated Bsk/Iyk revealed increased relative [32P]-incorporation into Bsk/Iyk isoforms containing the Y504F and Y497/504F mutations compared with wild-type Bsk/Iyk. The Y497F and Y497/504F mutations elevated the proportion of [32P]-incorporation into a 57 kDa Bsk/Iyk product relative to that into the 60 kDa isoform. The Y497F Bsk/Iyk mutant not only increased the relative amount of p57 Bsk/Iyk but also transferred this isoform to the nuclear subcellular fraction. The results suggest that Bsk/Iyk has unique regulatory properties, and that this kinase might serve a role in inhibiting cell replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9932229     DOI: 10.3109/08977199809002122

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  6 in total

1.  Characterization of mice deficient in the Src family nonreceptor tyrosine kinase Frk/rak.

Authors:  Subhashini Chandrasekharan; Ting Hu Qiu; Nawal Alkharouf; Kelly Brantley; James B Mitchell; Edison T Liu
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 2.  RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

3.  The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity.

Authors:  Michael Welsh; Charlotte Welsh; Maria Ekman; Johan Dixelius; Robert Hägerkvist; Cecilia Annerén; Björn Akerblom; Siavosh Mahboobi; Subhashini Chandrasekharan; Edison T Liu
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

4.  FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling.

Authors:  Xiuping Zhou; Lei Hua; Weijian Zhang; Ming Zhu; Qiong Shi; Feng Li; Liexiang Zhang; Chao Song; Rutong Yu
Journal:  J Neurooncol       Date:  2012-07-13       Impact factor: 4.130

5.  Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.

Authors:  Edward T Bagu; Sayem Miah; Chenlu Dai; Travis Spriggs; Yetunde Ogunbolude; Erika Beaton; Michelle Sanders; Raghuveera K Goel; Keith Bonham; Kiven E Lukong
Journal:  Oncotarget       Date:  2017-02-14

6.  FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition.

Authors:  Yetunde Ogunbolude; Chenlu Dai; Edward T Bagu; Raghuveera Kumar Goel; Sayem Miah; Joshua MacAusland-Berg; Chi Ying Ng; Rajni Chibbar; Scott Napper; Leda Raptis; Frederick Vizeacoumar; Franco Vizeacoumar; Keith Bonham; Kiven Erique Lukong
Journal:  Oncotarget       Date:  2017-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.